Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.
Also called NCT02232360
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Registry
-
NCT02232360
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02232360. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Rosuvastatin and fenofibrate
- Intervention (Drug)
- Rosuvastatin alone
- Lead sponsor
- Gachon University Gil Medical Center
- Collaborator
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct02232360- Content hash
d033748e87fc853bb2630e5d885bd86b58330396e3258a5acbe811e2d71421f1